Argus Cuts Biogen's Price Target to $200 From $250
J.P. Morgan Maintains Biogen(BIIB.US) With Hold Rating, Cuts Target Price to $210
Biogen Analyst Ratings
A Quick Look at Today's Ratings for Biogen(BIIB.US), With a Forecast Between $190 to $302
Biogen Price Target Cut to $180.00/Share From $190.00 by Barclays
Biogen Is Maintained at Buy by TD Cowen
TD Cowen Maintains Buy on Biogen, Lowers Price Target to $275
Redburn Atlantic Adjusts Price Target on Biogen to $190 From $230
Biogen Analyst Ratings
A Quick Look at Today's Ratings for Biogen(BIIB.US), With a Forecast Between $190 to $315
Biogen Price Target Maintained With a $270.00/Share by Needham
Morgan Stanley Downgrades Biogen to Equal-Weight, Lowers Price Target to $204
Needham Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $270
Needham Reiterates Buy on Biogen, Maintains $270 Price Target
Biogen Analyst Ratings
Truist Financial Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $302
Jefferies Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $250
Biogen's Strategic Shift: Felzartamab's Promise in IgAN and Beyond Fuels Buy Rating
Piper Sandler Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $307
Oppenheimer Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $270